Submitted by Anonymous (not verified) on 20 November 2024 - 15:57
Human medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 16, Status: Authorised
Source: